Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
- Conditions
- Portal HypertensionLiver Cirrhosis
- Interventions
- Drug: low molecular weight heparin
- Registration Number
- NCT03171727
- Lead Sponsor
- West China Hospital
- Brief Summary
Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction is defined as a loss of decompression of the portal venous system due to occlusion or stenosis of the TIPS. Occlusion of the TIPS can either be due to thrombosis or hyperplasia of the intima. Thrombosis of the TIPS usually occurs early and can happen within 24 hours of TIPS creation. The frequency of this complication is on the order of 10%-15% when bare stents are used. Post-TIPS short-term low molecular weight heparin (LMWH) was used to prevent the early thrombosis formation. Weather post-TIPS LMWH was necessary when polytetrafluoroethylene-covered stent was used during TIPS creation was not answered. The present study was designed to evaluate the effect of short-term use of LMWH on early TIPS dysfunction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 117
- Diagnosis of liver cirrhosis
- Technical success of TIPS was achieved.
- Non-cirrhotic portal hypertension
- Portal vein thrombosis
- Budd-Chiari syndrome
- Pregnancy
- Contradictions to anticoagulation therapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description study group low molecular weight heparin After TIPS procedure was performed, low molecular weight heparin was given for three days.
- Primary Outcome Measures
Name Time Method TIPS patency rate one year Analysis
- Secondary Outcome Measures
Name Time Method Mortality rate one year Analysis
LMWH-related complication one month Analysis
Trial Locations
- Locations (1)
West china Hospital
🇨🇳Chengdu, China